Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Patients with OSA exhibit a higher prevalence of vitamin D deficiency, and CPAP treatment has been reported to improve vitamin D levels.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin D Deficiency Is Associated with a Higher 5-Year Risk of Obstructive Sleep Apnea and CPAP Use in Older Adults: An Anchor-Based Network Meta-Analysis

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D Deficiency Is Associated with a Higher 5-Year Risk of Obstructive Sleep Apnea and CPAP Use in Older Adults: An Anchor-Based Network Meta-Analysis

Review / evidence synthesis · Medicina · 2026

Original publication title

Vitamin D Deficiency Is Associated with a Higher 5-Year Risk of Obstructive Sleep Apnea and CPAP Use in Older Adults: An Anchor-Based Network Meta-Analysis

Jui-Kun Chiang; Hsueh-Hsin Kao; Po-Han Chiang; Yee-Hsin Kao

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background and Objectives: Continuous positive airway pressure (CPAP) is the standard first-line treatment for patients with obstructive sleep apnea (OSA). Patients with OSA exhibit a higher prevalence of vitamin D deficiency, and CPAP treatment has been reported to improve vitamin D levels. Therefore, the aim of this study was to investigate the association between vitamin D deficiency and the risk of patients receiving a diagnosis of OSA or utilizing CPAP, using the TriNetX research network to obtain real-world data. Materials and Methods: A retrospective cohort study using the TriNetX database was conducted to investigate the relationship between vitamin D deficiency and patients with risk of receiving an OSA diagnosis or patients treated with CPAP in older adults (≥65 years).

Patients were stratified into four groups according to serum 25-hydroxyvitamin D [25(OH)D] levels: severe deficiency (D10, ≤10 ng/mL), mild deficiency (D20, 11 to 20 ng/mL), insufficient vitamin D status (S30, 21 to 30 ng/mL), and normal vitamin D status (N100, 31 to 100 ng/mL). After 1:1 propensity score matching (PSM) to adjust for baseline covariates, patients were followed for up to 5 years for newly diagnosed OSA and CPAP use (an administrative-clinical outcome influenced by non-disease-related factors such as healthcare access and clinical practice), with vitamin D status assessed at the index date.

An anchor-based network meta-analysis was also performed to integrate direct and indirect evidence across groups. Results: A total of 2,289,855 eligible patients were included and stratified into four groups: D10 (n = 161,610; 7.06%), D20 (n = 404,954; 17.68%), S30 (n = 648,989; 28.34%), and N100 (n = 1,074,302; 46.92%). Across the six pairwise comparisons, pre-matching baseline imbalances showed consistent patterns: lower vitamin D groups (particularly D10 and D20) generally had older age at index (in comparisons with S30 or D20), a higher proportion of males, and higher proportions of Black/African American patients, whereas higher vitamin D groups (especially N100 and S30) had higher proportions of White patients (and, in some comparisons, Asian patients).

Comorbidity differences were modest overall, and these imbalances were substantially reduced after PSM. In both pairwise PSM analyses and the anchor-based network meta-analysis, severe vitamin D deficiency was observationally associated with the risk of receiving an OSA diagnosis and CPAP use. An observational trend appeared across vitamin D categories (D10 > D20 > S30), suggesting an association. The associations were strongest at 1 year and gradually attenuated over the 3: and 5-year follow-up periods. An E-value greater than 3 was observed only for the comparison between the D10 and N100 groups. Conclusions: In this real-world analysis of older adults, vitamin D deficiency, particularly severe deficiency, was observationally associated with increased 5-year risk of receiving an OSA diagnosis and CPAP use.

Similarly, anchor-based network meta-analysis also showed an association between vitamin D deficiency severity and the risk of receiving an OSA diagnosis and CPAP use.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background and Objectives

Continuous positive airway pressure (CPAP) is the standard first-line treatment for patients with obstructive sleep apnea (OSA). Patients with OSA exhibit a higher prevalence of vitamin D deficiency, and CPAP treatment has been reported to improve vitamin D levels. Therefore, the aim of this study was to investigate the association between vitamin D deficiency and the risk of patients receiving a diagnosis of OSA or utilizing CPAP, using the TriNetX research network to obtain real-world data.

Source: Background and Objectives

Abstract: Results

A total of 2,289,855 eligible patients were included and stratified into four groups: D10 (n = 161,610; 7.06%), D20 (n = 404,954; 17.68%), S30 (n = 648,989; 28.34%), and N100 (n = 1,074,302; 46.92%). Across the six pairwise comparisons, pre-matching baseline imbalances showed consistent patterns: lower vitamin D groups (particularly D10 and D20) generally had older age at index (in comparisons with S30 or D20), a higher proportion of males, and higher proportions of Black/African American patients, whereas higher vitamin D groups (especially N100 and S30) had higher proportions of White patients (and, in some comparisons, Asian patients). Comorbidity differences were modest overall, and these imbalances were substantially reduced after PSM. In both pairwise PSM analyses and the anchor-based network meta-analysis, severe vitamin D deficiency was observationally associated with the risk of receiving an OSA diagnosis and CPAP use. An observational trend appeared across vitamin D categories (D10 > D20 > S30), suggesting an association. The associations were strongest at 1 year and gradually attenuated over the 3: and 5-year follow-up periods. An E-value greater than 3 was observed only for the comparison between the D10 and N100 groups.

Source: Results

Abstract: Conclusions

In this real-world analysis of older adults, vitamin D deficiency, particularly severe deficiency, was observationally associated with increased 5-year risk of receiving an OSA diagnosis and CPAP use. Similarly, anchor-based network meta-analysis also showed an association between vitamin D deficiency severity and the risk of receiving an OSA diagnosis and CPAP use.

Source: Conclusions
Authors’ abstract

Background and Objectives: Continuous positive airway pressure (CPAP) is the standard first-line treatment for patients with obstructive sleep apnea (OSA). Patients with OSA exhibit a higher prevalence of vitamin D deficiency, and CPAP treatment has been reported to improve vitamin D levels. Therefore, the aim of this study was to investigate the association between vitamin D deficiency and the risk of patients receiving a diagnosis of OSA or utilizing CPAP, using the TriNetX research network to obtain real-world data. Materials and Methods: A retrospective cohort study using the TriNetX database was conducted to investigate the relationship between vitamin D deficiency and patients with risk of receiving an OSA diagnosis or patients treated with CPAP in older adults (≥65 years).

Patients were stratified into four groups according to serum 25-hydroxyvitamin D [25(OH)D] levels: severe deficiency (D10, ≤10 ng/mL), mild deficiency (D20, 11 to 20 ng/mL), insufficient vitamin D status (S30, 21 to 30 ng/mL), and normal vitamin D status (N100, 31 to 100 ng/mL). After 1:1 propensity score matching (PSM) to adjust for baseline covariates, patients were followed for up to 5 years for newly diagnosed OSA and CPAP use (an administrative-clinical outcome influenced by non-disease-related factors such as healthcare access and clinical practice), with vitamin D status assessed at the index date.

An anchor-based network meta-analysis was also performed to integrate direct and indirect evidence across groups. Results: A total of 2,289,855 eligible patients were included and stratified into four groups: D10 (n = 161,610; 7.06%), D20 (n = 404,954; 17.68%), S30 (n = 648,989; 28.34%), and N100 (n = 1,074,302; 46.92%). Across the six pairwise comparisons, pre-matching baseline imbalances showed consistent patterns: lower vitamin D groups (particularly D10 and D20) generally had older age at index (in comparisons with S30 or D20), a higher proportion of males, and higher proportions of Black/African American patients, whereas higher vitamin D groups (especially N100 and S30) had higher proportions of White patients (and, in some comparisons, Asian patients).

Comorbidity differences were modest overall, and these imbalances were substantially reduced after PSM. In both pairwise PSM analyses and the anchor-based network meta-analysis, severe vitamin D deficiency was observationally associated with the risk of receiving an OSA diagnosis and CPAP use. An observational trend appeared across vitamin D categories (D10 > D20 > S30), suggesting an association. The associations were strongest at 1 year and gradually attenuated over the 3: and 5-year follow-up periods. An E-value greater than 3 was observed only for the comparison between the D10 and N100 groups. Conclusions: In this real-world analysis of older adults, vitamin D deficiency, particularly severe deficiency, was observationally associated with increased 5-year risk of receiving an OSA diagnosis and CPAP use.

Similarly, anchor-based network meta-analysis also showed an association between vitamin D deficiency severity and the risk of receiving an OSA diagnosis and CPAP use.

Publication and source details

Original title: Vitamin D Deficiency Is Associated with a Higher 5-Year Risk of Obstructive Sleep Apnea and CPAP Use in Older Adults: An Anchor-Based Network Meta-Analysis

Jui-Kun Chiang; Hsueh-Hsin Kao; Po-Han Chiang; Yee-Hsin Kao

Medicina · 2026

* Correspondence: 1010280uijk@gmail.com (P.-H.C.); m2200767@gmail.com (Y.-H.K.)
†

These authors contributed equally to this work.

© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T10:35:18.086292+00:00

DOI: 10.3390/medicina62050935 · PMC13208848